GlassScriptPhysician profile
Tiffany Benson
NPI 1356819478
$835.18
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $90.60 · 2023: $199 · 2024: $342 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $185.27 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $107.51 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $83.20 | 2023-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Astrazeneca Pharmaceuticals LP | $76.90 | 2023-2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $55.40 | 2024-2025 | Neffy, Odactra, Ragwitek |
| Cranial Technologies, INC | $55.32 | 2023-2025 | Doc Band |
| Tris Pharma INC | $51.36 | 2024-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $45.72 | 2022-2024 | |
| Pfizer INC. | $35.19 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $26.47 | 2023 | |
| Cipher Pharmaceuticals US LLC | $24.91 | 2025 | Spinosad, Natroba |
| Noven Therapeutics, LLC | $22.38 | 2025 | Xelstrym |
| Sanofi Pasteur INC. | $18.95 | 2023 | |
| Phadia US INC. | $17.82 | 2024 | Immunocap |
| Seqirus USA INC | $15.19 | 2023 | Flucelvax Quadrivalent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.